Q1 2024 Holdings
Filed 2024-05-06 | 16 holdings | $1.1B | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Dyne Therapeutics, Inc.(DYN) | Common Stock | 26818M108 | $227.7M | 8,020,136 | 21.0% |
| Kymera Therapeutics, Inc.(KYMR) | Common Stock | 501575104 | $216.2M | 5,377,362 | 19.9% |
| Disc Medicine, Inc.(IRON) | Common Stock | 254604101 | $142.4M | 2,287,233 | 13.1% |
| Day One Biopharmaceuticals, Inc.(DAWN) | Common Stock | 23954D109 | $106.2M | 6,430,257 | 9.8% |
| Third Harmonic Bio, Inc.(THRD) | Common Stock | 88427A107 | $103.0M | 10,907,859 | 9.5% |
| Korro Bio, Inc.(KRRO) | Common Stock | 500946108 | $100.7M | 1,119,292 | 9.3% |
| Aerovate Therapeutics, Inc. | Common Stock | 008064107 | $60.3M | 2,039,249 | 5.6% |
| Q32 Bio, Inc.(QTTB) | Common Stock | 746964105 | $35.6M | 2,092,106 | 3.3% |
| Generation Bio, Co.(GBIOGBX) | Common Stock | 37148K100 | $33.7M | 8,279,484 | 3.1% |
| Vigil Neuroscience, Inc.(VIGL) | Common Stock | 92673K108 | $19.9M | 5,836,874 | 1.8% |
| Replimune Group, Inc.(REPL) | Common Stock | 76029N106 | $17.1M | 2,098,300 | 1.6% |
| Ikena Oncology, Inc. | Common Stock | 45175G108 | $7.1M | 5,018,178 | 0.7% |
| AvroBio, Inc. | Common Stock | 05455M100 | $5.8M | 4,541,381 | 0.5% |
| Dianthus Therapeutics, Inc.(DNTH) | Common Stock | 252828108 | $5.6M | 186,979 | 0.5% |
| Xilio Therapeutics, Inc.(XLO) | Common Stock | 98422T100 | $1.1M | 992,912 | 0.1% |
| Spero Therapeutics, Inc.(SPRO) | Common Stock | 84833T103 | $1.0M | 607,613 | 0.1% |